133 related articles for article (PubMed ID: 11080541)
1. The antiviral compound 5-(3,4-dichlorophenyl) methylhydantoin inhibits the post-synthetic cleavages and the assembly of poliovirus in a cell-free system.
Verlinden Y; Cuconati A; Wimmer E; Rombaut B
Antiviral Res; 2000 Oct; 48(1):61-9. PubMed ID: 11080541
[TBL] [Abstract][Full Text] [Related]
2. Hydantoin: The mechanism of its in vitro anti-enterovirus activity revisited.
Tijsma A; Thibaut HJ; Franco D; Dallmeier K; Neyts J
Antiviral Res; 2016 Sep; 133():106-9. PubMed ID: 27485294
[TBL] [Abstract][Full Text] [Related]
3. Poliovirus 2C region functions during encapsidation of viral RNA.
Vance LM; Moscufo N; Chow M; Heinz BA
J Virol; 1997 Nov; 71(11):8759-65. PubMed ID: 9343235
[TBL] [Abstract][Full Text] [Related]
4. Poliovirus infection without accumulation of eclipse particles.
Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
Antiviral Res; 1995 Jan; 26(1):27-35. PubMed ID: 7741519
[TBL] [Abstract][Full Text] [Related]
5. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
[TBL] [Abstract][Full Text] [Related]
6. New small-molecule inhibitors effectively blocking picornavirus replication.
Ford Siltz LA; Viktorova EG; Zhang B; Kouiavskaia D; Dragunsky E; Chumakov K; Isaacs L; Belov GA
J Virol; 2014 Oct; 88(19):11091-107. PubMed ID: 25008939
[TBL] [Abstract][Full Text] [Related]
7. Action of 3-methylquercetin on poliovirus RNA replication.
Castrillo JL; Carrasco L
J Virol; 1987 Oct; 61(10):3319-21. PubMed ID: 2442414
[TBL] [Abstract][Full Text] [Related]
8. Identification and Analysis of Antiviral Compounds Against Poliovirus.
Leyssen P; Franco D; Tijsma A; Lacroix C; De Palma A; Neyts J
Methods Mol Biol; 2016; 1387():325-38. PubMed ID: 26983743
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of poliovirus RNA synthesis by brefeldin A.
Maynell LA; Kirkegaard K; Klymkowsky MW
J Virol; 1992 Apr; 66(4):1985-94. PubMed ID: 1312615
[TBL] [Abstract][Full Text] [Related]
10. Role of simvastatin and methyl-beta-cyclodextrin [corrected] on inhibition of poliovirus infection.
Liu S; Rodriguez AV; Tosteson MT
Biochem Biophys Res Commun; 2006 Aug; 347(1):51-9. PubMed ID: 16824485
[TBL] [Abstract][Full Text] [Related]
11. Antipoliovirus activity and mechanism of action of 3-methylthio-5-phenyl-4-isothiazolecarbonitrile.
Garozzo A; Stivala A; Tempera G; Castro A
Antiviral Res; 2010 Dec; 88(3):325-8. PubMed ID: 20955736
[TBL] [Abstract][Full Text] [Related]
12. 6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating.
González ME; Almela MJ; Yacout M; Carrasco L
Antimicrob Agents Chemother; 1990 Jun; 34(6):1259-61. PubMed ID: 2168147
[TBL] [Abstract][Full Text] [Related]
13. Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A.
Irurzun A; Perez L; Carrasco L
Virology; 1992 Nov; 191(1):166-75. PubMed ID: 1329315
[TBL] [Abstract][Full Text] [Related]
14. Brefeldin A inhibits cell-free, de novo synthesis of poliovirus.
Cuconati A; Molla A; Wimmer E
J Virol; 1998 Aug; 72(8):6456-64. PubMed ID: 9658088
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of poliovirus uncoating by disoxaril (WIN 51711).
Zeichhardt H; Otto MJ; McKinlay MA; Willingmann P; Habermehl KO
Virology; 1987 Sep; 160(1):281-5. PubMed ID: 2820136
[TBL] [Abstract][Full Text] [Related]
16. Potential use of antiviral agents in polio eradication.
De Palma AM; Pürstinger G; Wimmer E; Patick AK; Andries K; Rombaut B; De Clercq E; Neyts J
Emerg Infect Dis; 2008 Apr; 14(4):545-51. PubMed ID: 18394270
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiviral activity of four isothiazole derivatives against poliovirus type 1.
Pinizzotto MR; Garozzo A; Guerrera F; Castro A; La Rosa MG; Furneri PM; Geremia E
Antiviral Res; 1992 Jul; 19(1):29-41. PubMed ID: 1332598
[TBL] [Abstract][Full Text] [Related]
18. The poliovirus replication machinery can escape inhibition by an antiviral drug that targets a host cell protein.
Crotty S; Saleh MC; Gitlin L; Beske O; Andino R
J Virol; 2004 Apr; 78(7):3378-86. PubMed ID: 15016860
[TBL] [Abstract][Full Text] [Related]
19. Dominant drug targets suppress the emergence of antiviral resistance.
Tanner EJ; Liu HM; Oberste MS; Pallansch M; Collett MS; Kirkegaard K
Elife; 2014 Nov; 3():. PubMed ID: 25365453
[TBL] [Abstract][Full Text] [Related]
20. Intracellular vesicle acidification promotes maturation of infectious poliovirus particles.
Richards AL; Jackson WT
PLoS Pathog; 2012; 8(11):e1003046. PubMed ID: 23209416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
